Published in Blood Weekly, April 13th, 2000
The agreement calls for BPL to manufacture Haemacure's fibrin sealant products - Hemaseel APR and a frozen formula version of that product. Located just outside of London, in Elstree, United Kingdom, BPL is an agency of the National Blood Authority - National Health Agency (NHA).
In Fall 1999, Haemacure began ordering equipment, and the parties began work on plant layouts and with Immuno International AG on the transfer of technology to the Elstree facility. They are now working diligently to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.